---
title: "\"Performance\" Lao Heng He Brewing's annual loss narrowed to 514 million RMB"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281035771.md"
description: "Lao Heng He Brewing announced its annual results for 2025, with revenue recorded at RMB 272 million, a year-on-year decrease of 1.2%. The loss narrowed from RMB 517 million in the previous year to RMB 514 million, with a loss per share of 89 cents. No final dividend will be distributed"
datetime: "2026-03-30T14:01:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281035771.md)
  - [en](https://longbridge.com/en/news/281035771.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281035771.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/281035771.md) | [繁體中文](https://longbridge.com/zh-HK/news/281035771.md)


# "Performance" Lao Heng He Brewing's annual loss narrowed to 514 million RMB

Lao Heng He Brewing (02226.HK) announced its 2025 annual performance, with revenue recorded at RMB 272 million, a year-on-year decrease of 1.2%. The loss narrowed from RMB 517 million in the previous year to RMB 514 million, with a loss per share of 89 cents. No final dividend will be distributed

### Related Stocks

- [HONWORLD GP (02226.HK)](https://longbridge.com/en/quote/02226.HK.md)

## Related News & Research

- [A C-Suite executive at Pop Mart's biggest Chinese competitor explains what goes into making a hit toy like Labubu](https://longbridge.com/en/news/281606541.md)
- [Laopu Gold Co. Ltd. Class H (6181) Receives a Buy from CGS International](https://longbridge.com/en/news/281138022.md)
- [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/en/news/281325910.md)
- [Wuxi Lead Intelligent Equipment FY net profit amounted to RMB1,559.8 million](https://longbridge.com/en/news/281053550.md)
- [China Youran Dairy Further Delays Circular on Share Subscription and Whitewash Waiver](https://longbridge.com/en/news/281536370.md)